Eledon Pharmaceuticals In... (ELDN)
3.99
-0.16 (-3.86%)
At close: Mar 03, 2025, 3:59 PM
3.99
0.00%
After-hours: Mar 03, 2025, 03:59 PM EST
Eledon Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 4.61M | 56.41M | 84.83M | 114.19M | 8.79M | 12.97M | 17.23M | 23.22M | 24.02M | 105.26M | 31.75M | 11.69M |
| Short-Term Investments | 46.49M | n/a | n/a | n/a | n/a | n/a | n/a | 4.17M | 39.93M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 270K | n/a | n/a | n/a |
| Other Long-Term Assets | 186K | 150K | 400K | 383K | 639K | 869K | n/a | 120K | 45K | 200K | 80K | 20K |
| Receivables | n/a | n/a | n/a | 110K | 245K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | 1.29M | 881K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 5.03M | 3.11M | 3.51M | 1.32M | 935K | 1.3M | 1.77M | 47K | 3.28M | 2.27M | 425K | 235K |
| Total Current Assets | 56.13M | 59.52M | 88.35M | 115.63M | 9.97M | 14.28M | 19M | 29.54M | 67.17M | 107.51M | 32.18M | 11.93M |
| Property-Plant & Equipment | 365K | 739K | 768K | 138K | 321K | 14K | 25K | 98K | 489K | 33K | 29K | 16K |
| Goodwill & Intangibles | 32.39M | 32.39M | 81.03M | 81.03M | n/a | 1.87M | 1.87M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 32.94M | 33.27M | 82.2M | 81.56M | 960K | 2.75M | 1.89M | 218K | 804K | 233K | 109K | 36K |
| Total Assets | 89.07M | 92.79M | 170.55M | 197.19M | 10.93M | 17.03M | 20.89M | 29.76M | 67.97M | 107.74M | 32.29M | 11.96M |
| Account Payables | 967K | 2.2M | 1.81M | 1.37M | 329K | 689K | 418K | 338K | 1.21M | 765K | 5K | 764K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.45M | n/a | n/a | n/a | n/a |
| Short-Term Debt | 383K | 726K | 738K | 288K | 180K | n/a | n/a | 3.45M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 2.54M | 3.55M | 1.85M | 829K | 813K | 1.84M | 1.02M | 113K | 4.95M | 3.48M | 2.2M | 1.25M |
| Total Current Liabilities | 3.9M | 6.47M | 4.4M | 2.48M | 1.32M | 2.53M | 1.44M | 2.82M | 6.16M | 4.24M | 2.21M | 2.02M |
| Long-Term Debt | n/a | 383K | 400K | n/a | 144K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 76.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 88K | n/a | 85.34M | 49.84M |
| Total Long-Term Liabilities | 77.96M | 2.13M | 2.15M | 4.11M | 144K | 1.84M | 1.02M | 84K | 88K | n/a | 85.34M | 49.84M |
| Total Liabilities | 81.86M | 8.61M | 6.55M | 6.59M | 1.47M | 2.53M | 1.44M | 2.9M | 6.25M | 4.24M | 87.55M | 51.86M |
| Total Debt | 383K | 746K | 769K | 144K | 324K | n/a | n/a | 3.45M | n/a | n/a | n/a | n/a |
| Common Stock | 24K | 14K | 14K | 15K | 13K | 9K | 7K | 23K | 23K | 22K | n/a | n/a |
| Retained Earnings | -319.4M | -202.87M | -114.9M | -80.39M | -57.58M | -41.57M | -27.51M | -169.4M | -131.44M | -86.35M | -63.05M | -47.33M |
| Comprehensive Income | n/a | 0.00 | n/a | 0.00 | -0.00 | n/a | n/a | -1K | -55K | -58K | -43K | -51K |
| Shareholders Equity | 7.21M | 84.18M | 164M | 190.6M | 9.46M | 14.49M | 19.45M | 26.86M | 61.72M | 103.5M | -55.27M | -39.9M |
| Total Investments | 46.49M | n/a | n/a | n/a | n/a | n/a | n/a | 4.17M | 39.93M | n/a | n/a | n/a |